121
Views
13
CrossRef citations to date
0
Altmetric
GOVERNMENTAL REPORTS

Food and Drug Administration Recommends Against the Continued Use of Propoxyphene

Pages 80-82 | Published online: 24 Mar 2011

REFERENCES

  • Guidance for Industry—E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs. October 2005.
  • Beaver WT. Mild analgesics. A review of their clinical pharmacology. II. Am J Med Sci. 1966;251:576–599 concl.
  • Lasagna L. The clinical evaluation of morphine and its substitutes as analgesics. Pharmacol Rev. 1964;16:47–83.
  • Collins SL, Edwards JE, Moore RA, McQuay HJ. Single dose dextropropoxyphene, alone and with paracetamol (acetaminophen), for postoperative pain. Cochrane Database Syst Rev. 2000;(2):CD001440.
  • Collins SL, Edwards JE, Moore RA, McQuay HJ. Single-dose dextropropoxyphene in post-operative pain: a quantitative systematic review. Eur J Clin Pharmacol. 1998;54:107–112.
  • Veterans Health Administration Pharmacy Benefits Management Strategic Healthcare Group and Medical Advisory Panel. Review of the Efficacy and Safety of Propoxyphene. March 2006.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.